CysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancer - Wikidata - awgldk - TriplyDB

CysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancer

CysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancer

http://www.wikidata.org/entity/Q28536784

about

Eicosanoid pathway in colorectal cancer: Recent updates Evaluation of Cysteinyl Leukotriene Signaling as a Therapeutic Target for Colorectal Cancer Cysteinyl leukotrienes and their receptors: bridging inflammation and colorectal cancer Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function Cysteinyl leukotriene receptor 1 facilitates tumorigenesis in a mouse model of colitis-associated colon cancer.A potential anti-tumor effect of leukotriene C4 through the induction of 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells Phenotype-based Discovery of 2-[(E)-2-(Quinolin-2-yl)vinyl]phenol as a Novel Regulator of Ocular Angiogenesis.The eicosanoids leukotriene D4 and prostaglandin E2 promote the tumorigenicity of colon cancer-initiating cells in a xenograft mouse model Cytochrome P450 Oxidase 2C Inhibition Adds to ω-3 Long-Chain Polyunsaturated Fatty Acids Protection Against Retinal and Choroidal Neovascularization.An integrated network platform for contextual prioritization of drugs and pathways Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients.Critical analysis of carcinogenicity study outcomes. Relationship with pharmacological properties.Montelukast, current indications and prospective future applications.The impact of inflammatory lipid mediators on colon cancer-initiating cells.Montelukast reduces inhaled chlorine triggered airway hyperresponsiveness and airway inflammation in the mouse.Cysteinyl leukotriene 1 receptor influences intestinal polyp incidence in a gender-specific manner in the ApcMin/+ mouse model.Montelukast Induces Apoptosis-Inducing Factor-Mediated Cell Death of Lung Cancer Cells.CysLT1 Receptor Is Protective against Oxidative Stress in a Model of Irritant-Induced Asthma.Cysteinyl Leukotriene Receptor Antagonists Inhibit Migration, Invasion, and Expression of MMP-2/9 in Human Glioblastoma.M2-like macrophages induce colon cancer cell invasion via matrix metalloproteinases.Modulation of leukotriene signaling inhibiting cell growth in chronic myeloid leukemia.Montelukast inhibits hypoxia inducible factor-1α translation in prostate cancer cells.

P2860

Q26778011-A81C5971-19DC-4DC3-9335-BEABF5750795 Q28074285-37AAB753-5D36-4220-8EA8-2D0211033B7A Q28308101-0E597E2C-FE5B-48BE-9ED4-6ED24A79C47B Q33757657-4605EA9A-23F2-411C-BCEE-A6F51A8B7156 Q33798596-CFCC058C-6296-458D-9760-88F3CFCFD9B2 Q33798719-A9A4ED9C-8DB4-46BE-992D-265FB394FDB4 Q35914881-9EB38BB9-61AA-4AC6-8F49-8E1E9595890D Q36070194-02A83682-44D0-4EC1-ADF2-147E458661E4 Q36078137-C6C66733-13CA-4581-BF5E-641A2E7AA4D8 Q36746321-A49D65E5-5443-4040-AA43-E4268CDBA731 Q36774324-D004B199-39B7-4662-868B-F71FF929CF1D Q38818082-8F006666-0ABA-432D-A80F-D06D61A0CAF4 Q38835130-715F3BBE-EEFD-4629-B492-91F057914DE0 Q38963031-4E0E03C0-B381-4E37-95A2-3DBCF4334EF6 Q40118728-9FF9C1A2-4C4D-46B7-8BA1-FBCB98725A0D Q40852202-450AF44F-530B-4D07-9E87-943A87CD38CB Q41181320-07C17569-8260-4A56-BE39-2467A9320526 Q48222439-B8E74CF7-DBEB-4647-8700-B1F878A3168D Q48297033-55B1B8DA-6829-445E-BEC0-27D041E4BA94 Q51039609-84368414-501B-4F76-9F68-5006B7D642B0 Q51279012-C26107C9-FACF-46B1-9819-913CB516619B Q52715671-6EB41CB9-A6C4-4C0E-9D80-14CCC748AD33

P2860

CysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancer

http://www.wikidata.org/entity/Q28536784

description

2013 nî lūn-bûn

@nan

2013 թուականին հրատարակուած գիտական յօդուած

@hyw

2013 թվականին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

CysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancer

@ast

CysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancer

@en

CysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancer

@nl

type

label

CysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancer

@ast

CysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancer

@en

CysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancer

@nl

prefLabel

CysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancer

@ast

CysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancer

@en

CysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancer

@nl

P1433

Q28536784-6511DF21-ECAD-4165-8B56-0E121A348938

P1476

Q28536784-B08BEE8C-F6D4-4185-A4CF-3E92C6ED3C56

P2093

Q28536784-5137A843-8FFA-4713-852C-780817DA8343

Q28536784-98FFE092-8C08-4FC0-B894-D6F23B982000

Q28536784-B99007F7-32D7-4DFA-8816-72E67B2C9834

Q28536784-F719F80A-13EE-47DA-BC83-DEB8E88C8128

P2860

Q28536784-048C78B2-21C5-4227-9D27-B6403A3FDC50

Q28536784-09155130-43E0-431F-A080-B8F8B9C63BEB

Q28536784-09704C9D-FAD4-45DD-87CF-A22E9488C980

Q28536784-0A8BFB00-DB66-47A2-859C-7EFCD336FF71

Q28536784-0D638F29-1F6B-4519-BCE1-76C5C6B677E3

Q28536784-0D82A9BA-5206-48B2-8153-F574A6E4601A

Q28536784-11F684AE-EDD9-4922-9241-E0EC446520F0

Q28536784-1EA4D834-C665-49A3-A254-9D12057E32AF

Q28536784-31CCE80E-6D0C-468A-B0FF-ED99EF55F7F7

Q28536784-3540C405-9671-4967-A3E5-FF63229BEA63

P304

Q28536784-64530779-08E1-43A9-9803-06AB8F935988

P31

Q28536784-95A737E6-CB52-4A02-9037-5F1BC42CAFD9

P3181

Q28536784-83F07312-23C0-41AA-B74E-8179992DA671

P356

Q28536784-5D4A25D8-5670-42AE-9DE8-AB2BCE081734

P407

Q28536784-F4C98729-BED5-44C6-A7E4-205F7159E0B6

P433

Q28536784-435C7081-3087-4D74-BE85-168374A0D9A3

P478

Q28536784-D783C079-2113-4335-BBD4-0F92E1A67867

P50

Q28536784-88CF40EE-5C96-431F-9534-F866B8AB6C57

P577

Q28536784-994E99F2-EF18-4210-AE18-1DB9BCF52661

P5875

Q28536784-C079C7AE-292E-45E9-A0A0-5A1B8A771057

P698

Q28536784-0B00862E-DAE6-40DF-ABB8-B543AEC8E3B9

P921

Q28536784-F91C2011-E308-43A7-9B35-FB99E46DBDAD

P932

Q28536784-4CA1B0B1-AA76-4389-B839-D189764E3E36

P3181

P356

JOURNAL.PONE.0073466

P1433

P1476

CysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancer

@en

P2093

Anita Sjölander

http://www.w3.org/2001/XMLSchema#string

Minghui Liu

http://www.w3.org/2001/XMLSchema#string

Sayeh Savari

http://www.w3.org/2001/XMLSchema#string

Wondossen Sime

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of the human cysteinyl leukotriene CysLT1 receptor

Hallmarks of Cancer: The Next Generation

Ligand-induced tyrosine phosphorylation of cysteinyl leukotriene receptor 1 triggers internalization and signaling in intestinal epithelial cells

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors

Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas

Characterization of the human cysteinyl leukotriene 2 receptor.

Leukotrienes induce cell-survival signaling in intestinal epithelial cells.

Overexpression of cysteinyl LT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis.

Cysteinyl-leukotriene1 receptor is a potent target for the prevention and treatment of human urological cancer.

P304

e73466

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

212794

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0073466

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256614330

http://www.w3.org/2001/XMLSchema#string

P698

24039952

http://www.w3.org/2001/XMLSchema#string

P921

P932

3764114

http://www.w3.org/2001/XMLSchema#string